SMITH ALAN E - 26 Jul 2021 Form 3 Insider Report for Candel Therapeutics, Inc. (CADL)

Role: Director
Signature: /s/ Alan E. Smith
Issuer symbol: CADL
Transactions as of: 26 Jul 2021
Net transactions value: $0
Form type: 3
Filing time: 26 Jul 2021, 21:24:52 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CADL	Common Stock						32,548	26 Jul 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CADL	Stock Option (Right to Buy)							26 Jul 2021	Common Stock	4,068	$1.46	Direct	F1
holding	CADL	Stock Option (Right to Buy)							26 Jul 2021	Common Stock	16,274	$1.55	Direct	F2
holding	CADL	Stock Option (Right to Buy)							26 Jul 2021	Common Stock	16,274	$6.64	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of this option vested and became exercisable on May 28, 2019, with an additional 25% vesting on January 1, 2020 and the remainder vesting in 36 substantially equal monthly installments thereafter.
F2	This option is fully vested and exercisable as of the date hereof.